Millipore Q1 revs up 14% on pharma spending
Millipore says that rebounding Big Pharma spending and biotechnology drove first-quarter 2010 gains.
Archives for May 9, 2010
PDI cuts loss in Q1
A 38 per cent increase in revenues helped PDI cut its operating loss to $1.7m (€1.3m) in the first quarter, furthering the contract sales provider’s goal of achieving profitability by the end of the year.
Appointments at the EMA, SCM Pharma, Silence Therapeutics and Akrimax Pharmaceuticals – People on the move
in-PharmaTechnologist presents its latest round up of movements in the pharma sector, including appointments at the EMA, SCM Pharma, Silence Therapeutics and Akrimax Pharmaceuticals.
inVentiv Health to be bought for $1bn by THL
US private equity group Thomas H Lee Partners (THL) has confirmed that it will buy inVentiv Health
Levitra, Herceptin combo used to target brain metastases
Administration of Levitra (vardenafil) can increase Herceptin (trastuzumab) delivery to brain metastases, but not surrounding healthy tissue, increasing survival in mice, according to research.
TCGLS teams with Mantrax for Australian CRO market
Discovery services firm TCG Lifesciences (TCGLS) says its partnership with Mantrax Ventures “opens door” to Australian contract research sector.